HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Bertolini Selected Research

Daunorubicin (Cerubidine)

1/2018Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Bertolini Research Topics

Disease

71Neoplasms (Cancer)
03/2024 - 10/2002
31Breast Neoplasms (Breast Cancer)
01/2022 - 01/2003
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 09/2006
6Leukemia
10/2020 - 11/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2023 - 06/2002
5Lymphoma (Lymphomas)
01/2022 - 01/2003
5Neoplasm Metastasis (Metastasis)
01/2017 - 09/2004
4Triple Negative Breast Neoplasms
03/2023 - 11/2019
4Residual Neoplasm
10/2021 - 07/2012
4Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 06/2004
4Multiple Myeloma
01/2012 - 09/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 02/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 12/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
03/2023 - 10/2003
2Ovarian Epithelial Carcinoma
11/2022 - 01/2021
2Carcinogenesis
10/2020 - 02/2011
2COVID-19
10/2020 - 01/2020
2Disease Progression
01/2019 - 06/2012
2Obesity
11/2017 - 05/2013
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2015 - 12/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015 - 11/2008
2Type 2 Diabetes Mellitus (MODY)
03/2015 - 05/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2014 - 04/2008
2Hepatocellular Carcinoma (Hepatoma)
01/2014 - 07/2012
2Glioblastoma (Glioblastoma Multiforme)
01/2014 - 01/2013
2Inflammation (Inflammations)
05/2013 - 01/2007
2Carcinoma (Carcinomatosis)
11/2011 - 10/2009
2Melanoma (Melanoma, Malignant)
02/2011 - 10/2002
2Vascular Remodeling
10/2010 - 01/2008
2Colorectal Neoplasms (Colorectal Cancer)
10/2010 - 09/2003
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2005 - 10/2004
1Lung Neoplasms (Lung Cancer)
03/2024
1Cytopenia
11/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Pathologic Complete Response
01/2021
1Hematologic Diseases (Blood Diseases)
01/2021

Drug/Important Bio-Agent (IBA)

12Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2002
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2023 - 08/2003
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2016 - 01/2003
9Bevacizumab (Avastin)FDA Link
06/2015 - 09/2003
7Monoclonal AntibodiesIBA
01/2022 - 06/2002
5Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2012
4Vinorelbine (Navelbine)FDA LinkGeneric
03/2023 - 06/2015
4Metformin (Glucophage)FDA LinkGeneric
01/2022 - 05/2014
4Phosphotransferases (Kinase)IBA
10/2020 - 02/2011
4RNA (Ribonucleic Acid)IBA
10/2020 - 06/2004
4Capecitabine (Xeloda)FDA Link
06/2015 - 10/2008
4Angiogenesis InhibitorsIBA
10/2011 - 09/2003
3Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2022 - 04/2015
3AntibodiesIBA
01/2020 - 09/2002
3Immune Checkpoint InhibitorsIBA
11/2019 - 11/2017
3Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 03/2009
3Rituximab (Mabthera)FDA Link
01/2018 - 10/2003
3Paclitaxel (Taxol)FDA LinkGeneric
11/2011 - 09/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2010 - 05/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2023 - 08/2015
2Cytarabine (Cytosar-U)FDA LinkGeneric
03/2023 - 01/2018
2LigandsIBA
01/2022 - 11/2019
2AnthracyclinesIBA
01/2022 - 03/2009
2denatonium (denatonium benzoate)IBA
01/2021 - 01/2020
2Tyrosine Kinase InhibitorsIBA
10/2020 - 10/2015
2Trastuzumab (Herceptin)FDA Link
01/2018 - 05/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 04/2015
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2017 - 01/2017
2NVP-BKM120IBA
02/2016 - 12/2015
2Activin Receptors (Activin Receptor)IBA
01/2016 - 02/2011
2BiguanidesIBA
03/2015 - 05/2014
2EndoglinIBA
05/2014 - 12/2004
2Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2012 - 06/2012
2Lenalidomide (CC 5013)FDA Link
01/2012 - 10/2011
2GemcitabineFDA Link
11/2011 - 09/2008
2Cell-Free Nucleic AcidsIBA
10/2010 - 06/2004
2NucleotidesIBA
08/2010 - 01/2007
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2009 - 09/2004
2Cyclin D1IBA
10/2008 - 12/2005
2Cyclin D3IBA
10/2004 - 09/2003
1PlatinumIBA
03/2023
1EverolimusFDA Link
09/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2022
1CollagenIBA
01/2022
1Small Cytoplasmic RNAIBA
10/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020
1Tyrosine (L-Tyrosine)FDA Link
10/2020
1ibrutinibIBA
10/2020
1ARQ531IBA
10/2020
1venetoclaxIBA
01/2020
1130-nm albumin-bound paclitaxelIBA
11/2019
1AlbuminsIBA
11/2019
1atezolizumabIBA
11/2019

Therapy/Procedure

39Therapeutics
03/2023 - 01/2003
26Drug Therapy (Chemotherapy)
03/2022 - 01/2003
4Mammaplasty (Breast Reconstruction)
07/2015 - 01/2012
3Immunotherapy
03/2024 - 01/2022
3Transplantation
01/2021 - 09/2004
2Conservative Treatment
06/2017 - 07/2015
1Salvage Therapy
11/2022
1Heterologous Transplantation (Xenotransplantation)
01/2019